The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Standards for PET Image Acquisition and Quantitative Data Analysis
Open accessAbstract
Quantitative (18)F-FDG PET is increasingly being recognized as an important tool for diagnosis, determination of prognosis, and response monitoring in oncology. However, PET quantification with, for example, standardized uptake values (SUVs) is affected by many technical and physiologic factors. As a result, some of the variations in the literature on SUV-based patient outcomes are explained by differences in (18)F-FDG PET study methods. Various technical and clinical studies have been performed to understand the factors affecting PET quantification. On the basis of the results of those studies, several recommendations and guidelines have been proposed with the aims of improving the image quality and the quantitative accuracy of (18)F-FDG PET studies. In this contribution, an overview of recommendations and guidelines for quantitative (18)F-FDG PET studies in oncology is provided. Special attention is given to the rationale underlying certain recommendations and to some of the differences in various guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534 · cited 1×
“The main disadvantage of nonstandardized SUVs is that, although a proof of concept for various clinical applications has been demonstrated in several single-center studies, the results cannot be directly applied at other sites or in multicenter studies(45).Suchheterogeneitypartlyexplainswhyeventhe latestresponseevalua…”
BackgroundRevised Response Criteria for Malignant Lymphoma
Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., Coiffier, B., Fisher, R. I., Hagenbeek, A., Zucca, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2403 · Cited by 4,426
Young, H., Baum, R., Cremerius, U., Herholz, K., Hoekstra, O., Lammertsma, A. A., Pruim, J., & Price, P. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00229-4 · Cited by 1,720
Partial-Volume Effect in PET Tumor Imaging
Soret, M., Bacharach, S. L., & Buvat, I. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.035774 · Cited by 1,549
Juweid, M. E., Stroobants, S., Hoekstra, O. S., Mottaghy, F. M., Dietlein, M., Guermazi, A., Wiseman, G. A., Kostakoglu, L., Scheidhauer, K., Buck, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2305 · Cited by 1,335
Recommendations on the Use of 18F-FDG PET in Oncology
Fletcher, J. W., Djulbegovic, B., Soares, H. P., Siegel, B. A., Lowe, V. J., Lyman, G. H., Coleman, R. E., Wahl, R., Paschold, J. C., Avril, N., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.047787 · Cited by 1,101
SUV: standard uptake or silly useless value?
Keyes, J. W. (1995) · PubMed · Cited by 803
Shankar, L. K., Hoffman, J. M., Bacharach, S. L., Graham, M. M., Karp, J. S., Lammertsma, A. A., Larson, S. M., Mankoff, D. A., Siegel, B. A., den Abbeele, A. V., et al. (2006) · PubMed · Cited by 674
(2004) · PubMed · Cited by 653
Procedure guideline for tumor imaging with F-18 FDG PET/CT
Delbeke, D., Coleman, R. E., Guiberteau, M. J., Brown, M. L., Royal, H. D., Siegel, B. A., Townsend, D. W., Berland, L. L., Parker, J. A., Hübner, K. F., et al. (2006) · Cited by 620
Understanding the standardized uptake value, its methods, and implications for usage.
Thie, J. A. (2004) · PubMed · Cited by 546
A gradient-based method for segmenting FDG-PET images: methodology and validation
Geets, X., Lee, J. A., Bol, A., Lonneux, M., & Grégoire, V. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0363-4 · Cited by 419
(1993) · PubMed · Cited by 398
Boellaard, R., Oyen, W. J. G., Hoekstra, C. J., Hoekstra, O. S., Visser, E. P., Willemsen, A. T., Arends, B., Verzijlbergen, F. J., Zijlstra, J., Paans, A. M., et al. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0874-2 · Cited by 396
Self-citationLinden, H. M., Stekhova, S. A., Link, J. M., Gralow, J. R., Livingston, R. B., Ellis, G. K., Petra, P. H., Peterson, L. M., Schubert, E. K., Dunnwald, L. K., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3810 · Cited by 394
Use of PET for monitoring cancer therapy and for predicting outcome.
Weber, W. (2005) · PubMed · Cited by 341
Westerterp, M., Pruim, J., Oyen, W., Hoekstra, O., Paans, A., Visser, E., van Lanschot, J., Sloof, G., & Boellaard, R. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0224-1 · Cited by 294
Self-citationBastiaannet, E., Groen, H., Jager, P. L., Cobben, D. C. P., van der Graaf, W. T. A., Vaalburg, W., & Hoekstra, H. J. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.004 · Cited by 294
Krak, N. C., Boellaard, R., Hoekstra, O. S., Twisk, J. W. R., Hoekstra, C. J., & Lammertsma, A. A. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1566-1 · Cited by 283
Self-citationThe CT motion quantitation of lung lesions and its impact on PET-measured SUVs.
Erdi, Y. E., Nehmeh, S. A., Pan, T., Pevsner, A., Rosenzweig, K. E., Mageras, G. S., Yorke, E. D., Schöder, H. M., Hsiao, W., Squire, O. D., et al. (2004) · PubMed · Cited by 282
Hoekstra, C. J., Paglianiti, I., Hoekstra, O. S., Smit, E. F., Postmus, P. E., Teule, G. J. J., & Lammertsma, A. A. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050570 · Cited by 251
Hoekstra, C. J., Stroobants, S. G., Smit, E. F., Vansteenkiste, J., van Tinteren, H., Postmus, P. E., Golding, R. P., Biesma, B., Schramel, F. J. H. M., van Zandwijk, N., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.1189 · Cited by 247
Acquisition protocol considerations for combined PET/CT imaging.
Beyer, T., Antoch, G., Müller, S. P., Egelhof, T., Freudenberg, L. S., Debatin, J. F., & Bockisch, A. (2004) · PubMed · Cited by 231
(1969) · Radiology · doi:10.1148/23.1.186b · Cited by 220
Nestle, U., Kremp, S., & Grosu, A.-L. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.09.011 · Cited by 214
Standardised FDG uptake: A prognostic factor for inoperable non-small cell lung cancer
Borst, G. R., Belderbos, J. S. A., Boellaard, R., Comans, E. F. I., Jaeger, K. D., Lammertsma, A. A., & Lebesque, J. V. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.03.026 · Cited by 184
Self-citationTumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond
Mankoff, D. A., Eary, J. F., Link, J. M., Muzi, M., Rajendran, J. G., Spence, A. M., & Krohn, K. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0074 · Cited by 175
Monitoring response to treatment in patients utilizing PET
Avril, N. E., & Weber, W. A. (2005) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2004.09.006 · Cited by 171
Comparison of simplified quantitative analyses of FDG uptake
Graham, M. M., Peterson, L. M., & Hayward, R. M. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00143-8 · Cited by 169
Dunnwald, L. K., Gralow, J. R., Ellis, G. K., Livingston, R. B., Linden, H. M., Specht, J. M., Doot, R. K., Lawton, T. J., Barlow, W. E., Kurland, B. F., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4385 · Cited by 166
Influence of reconstruction iterations on 18F-FDG PET/CT standardized uptake values.
Jaskowiak, C., Bianco, J. A., Perlman, S. B., & Fine, J. P. (2005) · PubMed · Cited by 162
Initial experience with oral contrast in PET/CT: phantom and clinical studies.
Cohade, C., Osman, M., Nakamoto, Y., Marshall, L. T., Links, J. M., Fishman, E. K., & Wahl, R. L. (2003) · PubMed · Cited by 152
Simplified measurement of deoxyglucose utilization rate.
Hunter, G. J. S., Hamberg, L. M., Alpert, N. M., Choi, N. C., & Fischman, A. J. (1996) · PubMed · Cited by 150
Predictive and prognostic value of FDG‐PET in nonsmall‐cell lung cancer: A systematic review
de Geus‐Oei, L., van der Heijden, E. H. F. M., Corstens, F. H. M., & Oyen, W. J. G. (2007) · Cancer · doi:10.1002/cncr.22979 · Cited by 147
Dizendorf, E., Hany, T. F., Buck, A., von Schulthess, G. K., & Burger, C. (2003) · PubMed · Cited by 144
Quantifying the Effect of IV Contrast Media on Integrated PET/CT: Clinical Evaluation
Mawlawi, O. R., Erasmus, J. J., Munden, R. F., Pan, T., Knight, A. E., Macapinlac, H. A., Podoloff, D. A., & Chasen, M. H. (2006) · American Journal of Roentgenology · doi:10.2214/ajr.04.1740 · Cited by 143
Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET.
Hoekstra, C. J., Hoekstra, O. S., Stroobants, S. G., Vansteenkiste, J., Nuyts, J. L., Smit, E. F., Boers, M., Twisk, J. W. R., & Lammertsma, A. A. (2002) · PubMed · Cited by 136
Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy
Lowe, V. J. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)90601-0 · Cited by 133
Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine.
Schelbert, H. R., Hoh, C. K., Royal, H. D., Brown, M., Dahlbom, M. N., Dehdashti, F., & Wahl, R. L. (1998) · PubMed · Cited by 125
Coleman, R. E., Delbeke, D., Guiberteau, M. J., Conti, P. S., Royal, H. D., Weinreb, J. C., Siegel, B. A., Federle, M. P., Townsend, D. W., & Berland, L. L. (2005) · PubMed · Cited by 108
Gorospe, L., Raman, S., Echeveste, J., Avril, N. E., Herrero, Y., & ́ndez, S. H. (2005) · Nuclear Medicine Communications · doi:10.1097/01.mnm.0000171779.65284.eb · Cited by 106
The role of positron emission tomography with 18 F-fluoro-2-deoxy-D-glucose in respiratory oncology
Vansteenkiste, J., & Stroobants, S. G. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.17408020 · Cited by 103
Tumor metabolic rates in sarcoma using FDG PET.
Eary, J. F., & Mankoff, D. A. (1998) · PubMed · Cited by 101
Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET
Stahl, A. R., Ott, K., Schwaiger, M., & Weber, W. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1626-6 · Cited by 97
Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT.
Beyer, T., Antoch, G., Bockisch, A., & Stattaus, J. (2005) · PubMed · Cited by 92
Larson, S. M., & Schwartz, L. H. (2006) · PubMed · Cited by 87
Multicenter comparison of calibration and cross calibration of PET scanners.
Geworski, L., Knoop, B. O., de Wit, M., Ivančević, V., Bares, R., & Munz, D. L. (2002) · PubMed · Cited by 86
Sadato, N., Tsuchida, T., Nakaumra, S., Waki, A., Uematsu, H., Takahashi, N., Hayashi, N., Yonekura, Y., & Ishii, Y. (1998) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050256 · Cited by 86
Visvikis, D., Cheze-LeRest, C., Costa, D. C., Bomanji, J. B., Gacinovic, S., & Ell, P. J. (2001) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590100566 · Cited by 82
Fuzzy hidden Markov chains segmentation for volume determination and quantitation in PET
Hatt, M., Lamare, F., Boussion, N., Turzo, A., Collet, C., Salzenstein, F., Roux, C., Jarritt, P. H., Carson, K. J., Rest, C. C. L., et al. (2007) · Physics in Medicine and Biology · doi:10.1088/0031-9155/52/12/010 · Cited by 79
How should we analyse FDG PET studies for monitoring tumour response?
Lammertsma, A. A., Hoekstra, C. J., Giaccone, G., & Hoekstra, O. S. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0131-5 · Cited by 79
KIM, C. K., & Gupta, N. C. (1996) · Nuclear Medicine Communications · doi:10.1097/00006231-199610000-00011 · Cited by 72
Lartizien, C., Kinahan, P. E., Swensson, R. G., Comtat, C., Lin, M. C.-H., Villemagne, V. L., & Trébossen, R. (2003) · PubMed · Cited by 71
The integration of PET-CT scans from different hospitals into radiotherapy treatment planning
Öllers, M., Bosmans, G., van Baardwijk, A. A. W., Dekker, A. L. A. J., Lambin, P., Teule, J., Thimister, W., Rhami, A., & Ruysscher, D. D. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.12.025 · Cited by 65
Mankoff, D. A., Muzi, M., & Krohn, K. A. (2003) · Molecular Imaging and Biology · doi:10.1016/j.mibio.2003.09.002 · Cited by 39
Bourguet, P., Blanc-Vincent, M. P., Boneu, A., Bosquet, L., Chauffert, B., Corone, C., Courbon, F., Devillers, A., Foehrenbach, H., Lumbroso, J., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601088 · Cited by 38
PET for response assessment in oncology: radiotherapy and chemotherapy
Weber, W. (2005) · British Journal of Radiology · doi:10.1259/bjr/59640473 · Cited by 31
Alkhawaldeh, K. M., & Alavi, A. A. (2008) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e318184b3de · Cited by 30
Takahashi, Y., Oriuchi, N., Otake, H., Endo, K., & Murase, K. (2008) · Annals of Nuclear Medicine · doi:10.1007/s12149-008-0152-1 · Cited by 28
The Use of PET for Radiotherapy
Erdi, Y. E. (2007) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/1573405610703010003 · Cited by 17
Miller, J. C., Fischman, A. J., Aquino, S. L., Blake, M. A., Thrall, J. H., & Lee, S. I. (2007) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2006.10.011 · Cited by 12
Respiratory Sensation and Control of Breathing
Altose, M. D. (2007) · Current Respiratory Medicine Reviews · doi:10.2174/157339807779941730 · Cited by 3
Cited by
3D Slicer as an image computing platform for the Quantitative Imaging Network
Fedorov, A., Beichel, R., Kalpathy-Cramer, J., Finet, J., Fillion-Robin, J.-C., Pujol, S., Bauer, C., Jennings, D., Fennessy, F., Sonka, M., et al. (2012) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2012.05.001 · Cited by 9,023
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Boellaard, R., Delgado-Bolton, R., Oyen, W. J. G., Giammarile, F., Tatsch, K., Eschner, W., Verzijlbergen, F. J., Barrington, S. F., Pike, L. C., Weber, W. A., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2961-x · Cited by 3,303
“This requires reconstruction settings to be chosen such as to achieve matching convergence and spatial resolution across various systems and sites, especially within a multicentre setting [48, 58, 59].”
InfluentialSelf-citationRadiomics: the process and the challenges
Kumar, V., Gu, Y., Basu, S., Berglund, A., Eschrich, S. A., Schabath, M. B., Forster, K., Aerts, H. J. W. L., Dekker, A., Fenstermacher, D., et al. (2012) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2012.06.010 · Cited by 2,258
“PET–CT Quantitative imaging with 2-deoxy-2-[(18)F]fluoro-D-glucose (18-FDG) PET scans is a challenge because it not only requires calibration of the scanner and standardization of the scan protocol but also requires the patient and staff to adhere to a strict patient protocol [14,15].”
MethodBarrington, S. F., Mikhaeel, N. G., Kostakoglu, L., Meignan, M., Hutchings, M., Müeller, S. P., Schwartz, L. H., Zucca, E., Fisher, R. I., Trotman, J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5229 · Cited by 1,665
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Boellaard, R., O’Doherty, M. J., Weber, W. A., Mottaghy, F. M., Lonsdale, M. N., Stroobants, S. G., Oyen, W. J. G., Kotzerke, J., Hoekstra, O. S., Pruim, J., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1297-4 · Cited by 1,326
Self-citation
Metadata
- Authors
- Boellaard, R.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2009-04-20
- Volume
- 50
- Issue
- Suppl 1
- Pages
- 11S-20S
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2143967388
- Cited by
- 902
- References
- 62
- FWCI
- 31.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.